In the present study, we examined the spatial distribution of 18F-AV-1451 retention, likely representing the presence of hyperphosporylated tau pathology, in the brains of prodromal and clinically manifest AD patients in relation to the spatial extent of predefined templates of functional brain networks. The gene discussed is MAPT; the disease is Alzheimer disease.